These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27023622)

  • 1. Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.
    Kothari AN; Arffa ML; Chang V; Blackwell RH; Syn WK; Zhang J; Mi Z; Kuo PC
    J Clin Med; 2016 Mar; 5(4):. PubMed ID: 27023622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms.
    Viana BPPB; Gomes AVP; Gimba ERP; Ferreira LB
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity.
    Jia R; Liang Y; Chen R; Liu G; Wang H; Tang M; Zhou X; Wang H; Yang Y; Wei H; Li B; Song Y; Zhao J
    Cell Death Dis; 2016 Dec; 7(12):e2564. PubMed ID: 28032860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
    Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
    Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
    Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
    Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
    Wang Y; Wu Z; Hu L
    Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT-ions with a TWIST between EMT and MET.
    Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
    Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB proteins link cell motility with cell cycle control and cell survival in cancer.
    Browne G; Sayan AE; Tulchinsky E
    Cell Cycle; 2010 Mar; 9(5):886-91. PubMed ID: 20160487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.
    Díaz VM; de Herreros AG
    Semin Cancer Biol; 2016 Feb; 36():71-9. PubMed ID: 26506454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Regulation of Epithelial to Mesenchymal Transition.
    Abba ML; Patil N; Leupold JH; Allgayer H
    J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26784241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway.
    Yu X; Zheng Y; Zhu X; Gao X; Wang C; Sheng Y; Cheng W; Qin L; Ren N; Jia H; Dong Q
    Oncol Lett; 2018 Oct; 16(4):5299-5308. PubMed ID: 30250599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
    Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
    Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET.
    Goossens S; Vandamme N; Van Vlierberghe P; Berx G
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):584-591. PubMed ID: 28669750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
    Bonavida B; Baritaki S
    Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines.
    Li NY; Weber CE; Wai PY; Cuevas BD; Zhang J; Kuo PC; Mi Z
    Surgery; 2013 Aug; 154(2):404-10. PubMed ID: 23889968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
    Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
    Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy.
    Chou YS; Yang MH
    J Chin Med Assoc; 2015 Aug; 78(8):438-45. PubMed ID: 26078096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts.
    Baulida J
    Mol Oncol; 2017 Jul; 11(7):847-859. PubMed ID: 28544627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.